Zhao’s research addresses development of highly bioavailable drugs by targeting active drug transporters, with focus on issues of blood brain barrier-associated drug transport proteins and CADD-based molecular design of target selective drugs that can be substrates for such transporters and actively delivered into the central nervous system.